CN101768637B - Kit for simultaneously detecting mutations in mitochondria DNA A1555G and C1494T and using method thereof - Google Patents

Kit for simultaneously detecting mutations in mitochondria DNA A1555G and C1494T and using method thereof Download PDF

Info

Publication number
CN101768637B
CN101768637B CN2009102232638A CN200910223263A CN101768637B CN 101768637 B CN101768637 B CN 101768637B CN 2009102232638 A CN2009102232638 A CN 2009102232638A CN 200910223263 A CN200910223263 A CN 200910223263A CN 101768637 B CN101768637 B CN 101768637B
Authority
CN
China
Prior art keywords
primer
sequence
sudden change
dna
mitochondrial dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102232638A
Other languages
Chinese (zh)
Other versions
CN101768637A (en
Inventor
管敏鑫
吕建新
李智渊
朱翌
杨爱芬
郑静
唐霄雯
王金丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wenzhou Medical College
Original Assignee
Wenzhou Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wenzhou Medical College filed Critical Wenzhou Medical College
Priority to CN2009102232638A priority Critical patent/CN101768637B/en
Publication of CN101768637A publication Critical patent/CN101768637A/en
Application granted granted Critical
Publication of CN101768637B publication Critical patent/CN101768637B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a kit for simultaneously detecting mutations in mitochondria DNA A1555G and C1494T related to maternally inherited drug-induced deafness and a using method thereof. The kit comprises a reagent for extracting sample genomic DNA, a PCR amplification reactive reagent, a primer mixed liquor, a positive control template and a negative control template. The using method of the kit mainly comprises the following steps: using blood, hair with follicle, oral mucosa doctor blade, saliva, and the like, as a sample; adopting a proteinase K digestion pyrolysis method to extract genomic DNA; and then simultaneously detecting mutations in A1555G and C1494T by multiple allele specific PCR. The kit is used for detecting the mutations in mitochondria DNA A1555G and C1494T related to maternally inherited drug-induced deafness and is more rapid, economical and simpler than the single detection for mutation in A1555G or C1494T, and the kit has low requirements for equipment and environment and is conducive to promotion and application.

Description

The test kit and the method for use thereof that are used for while detection line mitochondrial DNA A1555G and C1494T sudden change
Technical field
The present invention relates to a kind of test kit and method of use thereof that is used for detecting simultaneously Mitochondrial DNA A1555G relevant and C1494T sudden change with the matrilinear inheritance drug induced deafness.
Background technology
Mitochondrial DNA (Mitochondria DNA, mtDNA) sudden change is one of major reason that causes phonosensitive nerve deafness, these sudden changes mainly are positioned on plastosome 12S rRNA and the tRNA gene.Be positioned at homogeneity A1555G and the C1494T sudden change and aminoglycoside antibiotics (Aminoglycoside Antibiotics of 12SrRNA gene; AmAn) deaf relevant (the Prezant TR etal. of the non-syndrome type that causes; Nat Genet, 1993,4:259-294; Guan MX, Ann N Y Acad Sci, 2004,1011:259-271; Fischel Ghodsian, Pharmacogenomics, 2005,6:27-36).Although mtDNAA1555G or C1494T sudden change itself can cause deafness, most A1555G or C1494T carriers of mutation the hearing irreversible loss occurs after having used AmAn (like Streptomycin sulphate, qingfengmeisu qiong, kantlex, tobramycin, micronomicin etc.).Though there was the microbiotic of many novel powerfuls constantly to come out in recent years; But characteristics such as AmAn is cheap with it, has a broad antifungal spectrum, germicidal action are fast; Still be widely used clinically (especially for the treatment gram positive bacterial infection), its consequence is in deaf crowd, to occupy higher ratio by the deaf case that AmAn causes.The individuality that carries these two sudden changes is extremely sensitive to AmAn, causes common clinically " pin causes deaf " phenomenon, is acquired deaf major reason (Fischel-Ghodsian N, Hum Mutat, 1999, the 13:261-270 that the takes place day after tomorrow; Guan MX, Ann N Y AcadSci, 2004,1011:259-271; Van Camp G et al., C lin Genet, 2000,57:409-414.), especially at China remote countryside area, this situation ubiquity.At present; Only the matrilineal inherited deafness family of the mtDNAA1555G of Zhejiang area discovery or C1494T sudden change is above 80; 1 carriers of mutation of average discovery; Just can carry out early intervention, avoid the use of aminoglycoside antibiotics medicine in this crowd, can effectively reduce the generation of drug induced deafness about 17 maternal members that do not fall ill in its family.Therefore, in high risk population and Susceptible population, carry out the examination of mtDNA12S rRNA transgenation, for the important role that has of prevention and control matrilinear inheritance drug induced deafness.
Since nineteen ninety-three; Both at home and abroad to the detection of mtDNA A1555G sudden change except PCR directly checks order; Widespread usage PCR-restriction fragment length polymorphism (PCR-RFLP) technology identifies that used restriction enzyme is Alw26 I (BsmA I) (Fischel Ghodsian et al., Am J Otolaryngol; 1993,14:399-403; Fischel Ghodsian et al., Am J Otolaryngol, 1997b, 18:173-178).Since the relation of finding mtDNA C1494T sudden change and drug induced deafness, the detection method in this mutational site mainly still sequencing (Guan MX, Ann N Y Acad Sci, 2004,1011:259-271).Direct sequencing is a golden standard of identifying sudden change, but this complex operation, expensive has limited its widespread use.Though it is convenient and swift that enzyme is cut evaluation, reliable results, insufficient Alw26 I (BsmA I) enzyme price is more expensive, compares with Restriction Enzyme commonly used, and price variance reaches 50~100 times.
In recent years; Domestic improvement PCR-RFLP technology and the fluorescent quantitative PCR technique reported in succession; To satisfy the needs that mtDNAA1555G and C1494T are suddenlyd change and carry out extensive examination; " detection method and the test kit thereof of 1555 A of matrilineal inherited deafness chondriogen → G sudden change " (publication number: CN1490415) like people such as Dai Piao research and development; " being used to probe that detects matrilinear inheritance chondriosome deafness gene A 1555 G and uses thereof " (publication number: CN1987462), " being used to Taqman MGB probe that detects matrilinear inheritance chondriosome deafness gene C 1494 T mutation and uses thereof " (publication number: CN1987463).Though these detection methods have reduced cost to a certain extent, operation steps is easy not enough, can not detect mtDNAA1555G and C1494T sudden change simultaneously; To some degree, testing cost still is higher, and this is still a no small spending concerning the people of many families Ji difficulty.Crystalline substance
Figure G2009102232638D00021
the hereditary hearing impairment gene diagnosis chip test kit of rich biological autonomous innovation research and development difficult to understand be for quick, the known hereditary hearing impairment gene mutation site of high-throughput examination is custom-designed; Adopted the principle of gene chip; Detect 4 deaf-related gene (GJB2 simultaneously; GJB3, SLC26A4 and 12S rRNA) 9 mutantional hotspots.But the gene chip kit detection relates to specific apparatus and the bulk data Treatment Analysis is had relatively high expectations to laboratory equipment, environment and operator, and expensive, is difficult to promote the use of in general hospital or laboratory.Traditionally, the method that obtains the deafness patient genomic dna is from blood, to extract, and everyone approximately needs 3~5ml.This blood-sampling method has brought some painful and injuries to a lot of examinees especially infant, and when trans-regional transfer samples, has certain risk and trouble.Therefore; Pressing for does not a kind ofly have the method for obtaining the deafness patient genomic dna and a kind of quick, easy, accurate, economic drug induced deafness associated gene mutation detection method of injury, no pain to human body, to satisfy the needs that mtDNA A1555G and C1494T are suddenlyd change and carry out extensive examination.
Summary of the invention
To above-mentioned shortcoming, the present invention provides a kind of test kit that is used for detecting simultaneously Mitochondrial DNA A1555G relevant with the matrilinear inheritance drug induced deafness and C1494T sudden change, and this test kit comprises:
(1) reagent of extraction sample genomic dna;
(2) pcr amplification reaction reagent comprises dNTP, 10 * PCR damping fluid, MgCl 2, Taq enzyme and tri-distilled water;
(3) two pipe primers, wherein a pipe is the mixed solution of primer C1, N1, N2 and C2, another pipe is the mixed solution of primer C1, M1, M2 and C2;
Said two pipe primers are according to the human mtdna sequences Design shown in the SEQ ID NO:7; Article one, primer sequence N1 is an antisense strand; Being the downstream universal primer, is the Nucleotide 1494-1516 of Mitochondrial DNA, and its sequence is the SEQ ID NO:1 in the sequence table; Second primer sequence M1 is an antisense strand, is the downstream universal primer, is the Nucleotide 1494-1516 of Mitochondrial DNA, and wherein the G in 1494 sites is replaced into A, and its sequence is the SEQ ID NO:2 in the sequence table; Article three, primer sequence C1 is a sense strand, is upper reaches universal primer, is the Nucleotide 1030-1052 of Mitochondrial DNA, and its sequence is the SEQID NO:3 in the sequence table; Article four, primer sequence N2 is a sense strand, is upper reaches universal primer, is the Nucleotide 1533-1555 of Mitochondrial DNA, and its sequence is the SEQ ID NO:4 in the sequence table; Article five, primer sequence M2 is a sense strand, is upper reaches universal primer, is the Nucleotide 1533-1555 of Mitochondrial DNA, and wherein the A in 1555 sites is replaced into G, and its sequence is the SEQ ID NO:5 in the sequence table; Article six, primer sequence C2 is an antisense strand, is the downstream universal primer, is the Nucleotide 2214-2235 of Mitochondrial DNA, and its sequence is the SEQ ID NO:6 in the sequence table;
(4) carry A1555G sudden change the positive control template, carry the positive control template and the negative control template of C1494T sudden change.
In above-mentioned primer, 3 ' end of primer N1 and M1 is positioned at 1494 sites of Mitochondrial DNA, corresponds respectively to 1494 site wild-type G and mutant A; 3 ' end of primer N2 and M2 is positioned at 1555 sites of Mitochondrial DNA, corresponds respectively to 1555 site wild-type A and mutant G (with reference to Fig. 1).
In above-mentioned primer; Introducing sulfuration phosphoric acid between first of every primer 3 ' end and second bit base modifies; And 3 of primer N1, M1, N2 and M2 ' end the 4th bit base is introduced mispairing; Promptly be replaced into A corresponding to mitochondrial 1497 G, 1552 G is replaced into A, to improve the specificity of extension.
In above-mentioned primer, N1 and C1 pairing is used to increase and contains the mitochondria DNA fragment in the normal site of C1494C, and N2 and C2 match to be used to increase and contain the mitochondria DNA fragment in the normal site of A1555A; M1 and C1 pairing is used to increase and contains the mitochondria DNA fragment in C1494T mutational site, and M2 and C2 match to be used to increase and contain the mitochondria DNA fragment in A1555G mutational site; Primer C1 and C2 pairing are used to generate a constant amplified band, as the molecule internal control index of PCR reaction.
In the reagent of said extracted sample genomic dna, comprise cell pyrolysis liquid and solution I, the staple of said solution I is a Proteinase K.In above-mentioned pcr amplification reaction reagent, add DMSO 99.8MIN., to improve the extension specificity.
The present invention also provides the method for use of mentioned reagent box, and this method of use may further comprise the steps:
(1) extraction of genomic dna: use the reagent of above-mentioned extraction sample genomic dna,, from tested sample, extract genomic dna through the protease K digesting cracking process;
(2) multiple allele-specific pcr amplification (Multiplex Allele-specific PCR, MASPCR): use above-mentioned pcr amplification reaction reagent and two pipe primers, the genomic dna of sample is carried out the MASPCR amplification; The present invention combines allele-specific round pcr and multiple PCR technique; Every part of dna sample is that primer C1, N1 and N2, C2 and primer C1, M1 and M2, C2 carry out the MASPCR amplification in two PCR reaction tubess with two pairs of allele-specific primerses respectively, just can in 2~3 hours, detect C1494T sudden change and A1555G sudden change simultaneously through a PCR.
(3) sudden change detects: agarose gel electrophoresis detects, the dna fragmentation quantity and the dna fragmentation size that directly produce according to pcr amplification, and whether the detection line mitochondrial DNA A1555G sudden change and C1494T sudden change take place simultaneously.
In the extraction step of above-mentioned genomic dna, can be from 20~200 μ l blood samples, 1cm 2Hair, oral mucosa scraping blade or the saliva sample of blood filter paper, band hair follicle in the rapid extraction genomic dna, different according to sampling mode or tested sample form, different samples are carried out corresponding pre-treatment.
(1) gets 20~200 μ l blood sample or 1cm 2The blood filter paper put into 1.5ml EP pipe (Eppendorf pipe), add 900 μ l erythrocyte splitting damping fluid (20mmol/L Tris-HCl, pH 7.6) room temperatures and leave standstill 10min, abundant splitting erythrocyte, the centrifugal 1min of 12000rpm collects white corpuscle and precipitates;
(2) wash the hair 1 time of band hair follicle with 70% ethanol, after use the distilled water flushing hair again 2 times.In 1.5ml EP pipe, put into 2~4 hairs respectively, hair follicle places EP pipe bottom, cuts off the part that hair is higher than the EP pipe with clean scissors;
(3) before the collection saliva, must let the person of being collected gargle.To remove materials such as aged cells too much in the oral cavity, swill, toothpaste, coffee, cigarette.Do not drink water in half a hour, feed, smoking, begin to collect oral mucosa scraping blade or saliva then, visual condition selects following method to collect saliva sample: 1. tongue is scraped around the oral cavity and is got mucomembranous cell, will about 0.1ml saliva directly tells in the EP pipe; 2. saline water is gargled, and tells in the EP pipe, draws PBS solution to the EP pipe that the saliva sample of collecting through above-mentioned any method is housed, and after the piping and druming, the centrifugal 5min of 12000rpm removes supernatant, repeats this process once repeatedly; 3. scrape the cheek inwall repeatedly 6 times with cotton swab, air drying carefully tears its outside surface off with the tweezers of sterilizing then, puts into the EP pipe; 4. saliva is told on filter paper, form salivary stain behind the air drying, be cut into the about 1cm of size with clean scissors again 2A scrap of paper places the EP pipe.
With cell pyrolysis liquid and Proteinase K above-mentioned sample is digested cracking then, salting-out process is removed impurity such as albumen again, and isopropanol precipitating DNA is subsequent use in-20 ℃ of preservations with autoclaving water or TE damping fluid dissolving back at last.
With 4 pairs of primers that the present invention designed; DNA with respective sample is a template respectively, the constant amplified band through obtaining the about 1206bp of size limpid in sight behind the pcr amplification respectively, corresponding to the 703bp electrophoretic band in 1555 sites and corresponding to the 487bp electrophoretic band in 1494 sites.Proof primer 3 ' end is introduced base mismatch and is carried out the efficient that thio-modification does not influence PCR.
When normal sample promptly do not carry plastosome A1555G and C1494T the sudden change genomic dna after two couples of primer C1, N1 and N2, C2 carry out MASPCR; Except producing a constant amplified band of 1206bp, also produce 2 and correspond respectively to the 703bp in 1555 sites, 1494 sites and the normal amplified band of 487bp; And behind two couples of C1, M1 and M2, C2 primer amplification, only produce the constant amplified band of a 1206bp, prove that this sample does not contain mtDNA A1555G sudden change and C1494T sudden change.When the genomic dna that carries mtDNAA1555G sudden change deafness patient after two couples of primer C1, N1 and N2, C2 carry out MASPCR, normal amplified band and constant amplified band of 1 487bp appearred; And after two couples of primer C1, M1 and M2, C2 amplification, sudden change amplified band and constant amplified band of 1 703bp appearred, proved that this sample carries mtDNA A1555G sudden change.When the genomic dna that carries mtDNA C1494T sudden change deafness patient after two couples of primer C1, N1 and N2, C2 carry out MASPCR, normal amplified band and constant amplified band of 1 703bp appearred; And after two couples of primer C1, M1 and M2, C2 amplification, sudden change amplified band and constant amplified band of 1 487bp appearred, proved that this sample carries mtDNA C1494T sudden change (with reference to Fig. 2).
In theory; Sample genomic dna is through a PCR reaction; Be only to add in the system just can detect to mutant site (1494T/1555G) primer C1, M1 and M2, C2; But we also use primer C1, N1 and N2, C2 to detect wild-type site (C1494/A1555), authenticate reverse experimental result simultaneously.That is to say that same sample genomic dna is realized bi-directional verification, thereby made detected result more accurate, credible through twice PCR.
Test kit of the present invention and method of use thereof have following characteristics:
1. the method that obtains the deafness patient genomic dna traditionally is from blood, to extract, and everyone approximately needs 3~5ml.This blood-sampling method has brought some painful and injuries to a lot of examinees especially infant, and when trans-regional transfer samples, has certain risk and trouble.Use test kit of the present invention, can from one bleed the liquid sample, the band hair follicle hair, oral mucosa scraping blade or saliva equal samples the rapid extraction genomic dna.This method has not only solved the problem of from deafness patient blood, extracting DNA traditionally, alleviates examinee's misery, but also has solved the problem of trans-regional transfer samples.Blood filter paper, hair and oral mucosa scraping blade (cotton swab) or salivary stain filter paper etc. can be placed in the envelope easily, and can be through the trans-regional transmission of mode of mailing.
2. primer used in the test kit of the present invention is all through careful design.At first, normally with mutation allele between different bases be designed in 3 of each bar primer ' end, thereby improved the specificity that increases greatly; The product that is obtained by primer C1 and C2 pairing amplification in addition can be used as the molecule internal control index of whole PCR reaction, thereby avoids the appearance of false negative result, improves the stability of detected result.Concentration through adjusting different primers and ratio and the PCR reaction conditions is optimized are with specificity and the stability of guaranteeing the result.
3. several kinds of matrilinear inheritance induced deafness gene testers are arranged at present both at home and abroad; Cut identification method, fluorescent quantitative PCR detection method, gene chip detection method etc. like direct sequencing, enzyme; Because himself defective, as waste time and energy, complex operation and testing cost be higher and be difficult for promoting clinical.Compare with these methods, test kit provided by the invention relates to multiple allele-specific round pcr, in conjunction with allele-specific round pcr and both advantages of multiple PCR technique.Every part of dna sample is that primer C1, N1 and N2, C2 and primer C1, M1 and M2, C2 carry out the MASPCR amplification in two PCR reaction tubess with two pairs of allele-specific primerses respectively, just can in 2~3 hours, detect C1494T sudden change and A1555G sudden change simultaneously through a PCR.
4. use test kit provided by the invention and carry out mtDNAA1555G and C1494T sudden change detection, cost is lower than other detection methods; Testing process is easy, quick, and interpretation is directly perceived as a result; Experimental installation and operator there is not particular requirement; Be adapted at general hospital, carry out in the molecular biosciences laboratory; Be convenient to the particularly extensive examination and the preventive inspection of low developed area implementation matrilinear inheritance drug induced deafness mtDNA A1555G and C1494T sudden change in China, effectively reduce the chance that drug induced deafness takes place the responsive crowd of aminoglycoside antibiotics.
Description of drawings
Fig. 1 is a multiple allele-specific PCR primer synoptic diagram of the present invention;
Fig. 2 is a multiple allele-specific pcr amplification scheme synoptic diagram of the present invention;
Fig. 3 is the matrilinear inheritance drug induced deafness family family tree that carries A1555G sudden change (WZD34 family) and C1494T sudden change (WZD102 family);
Fig. 4 is the 2% agarose gel electrophoresis figure that multiple allele-specific pcr amplification is identified mtDNA A1555G and C1494T sudden change.
Nomenclature
C1 is a upper reaches universal primer; N1 is the normal primer sequence, and 3 ' end is positioned at 1494, corresponding to 1494 site wild-type G, uses with the C1 pairing; M1 is the mutant primer sequence, and 3 ' end is positioned at 1494, corresponding to 1494 site mutation type A, uses with the C1 pairing; C2 is the downstream universal primer; N2 is the normal primer sequence, and 3 ' end is positioned at 1555, corresponding to 1555 site wild-type A, uses with the C2 pairing; M2 is the mutant primer sequence, and 3 ' end is positioned at 1555, corresponding to 1555 site mutation type G, uses with the C2 pairing; 1494C representes that 1494 sites of Mitochondrial DNA are wild-type C; 1494T representes that 1494 sites of Mitochondrial DNA are mutant T; 1555A representes that 1555 sites of Mitochondrial DNA are wild-type A; 1555G representes that 1555 sites of Mitochondrial DNA are mutant G; is that normal male is individual among the figure; Zero is normal female individual; ■ is the morbidity male individual; ● be the morbidity female individual;
Figure G2009102232638D00081
is the propositus; * be aminoglycoside medicaments induced deafness patient; / be dead individuality; I is the first-generation member of this family; II is the s-generation member of this family; III is the third generation member of this family; A representes the electrophorogram of PC R amplification (C1, N1, N2, C2) product of wild-type site detection; B representes the electrophorogram of PCR (C1, M1, M2, the C2) amplified production that the mutant site is detected; Y1 is the propositus (WZD102-III-1) who carries the C1494T sudden change; Y2 is father propositus (WZD102-II-1) who carries the C1494T sudden change; Y3 is mother propositus (WZD102-II-2) who carries the C1494T sudden change; Y4 is the propositus (WZD34-III-2) who carries the A1555G sudden change; Y5 is father propositus (WZD34-II-1) who carries the A1555G sudden change; Y6 is mother propositus (WZD34-II-2) who carries the A1555G sudden change; The negative contrast template of Y7; Y8 is the positive control template of carrying the C1494T sudden change; Y9 is the positive control template of carrying the A1555G sudden change; Y10 is no template blank; YM is DL2000 DNA Marker.
Embodiment
Below in conjunction with nucleotide sequence table, accompanying drawing and specific embodiment the present invention is described further so that those skilled in the art can better understand the present invention and implementing, but the embodiment that lifts not conduct to qualification of the present invention.
Embodiment 1
1. design of primers
Use Primer 5.0 softwares and Oligo7.0 software assistance design improved primer; According to disclosed human mtdna Cambridge reference sequences (Human Mitochondrial DNA Revised CambridgeReference Sequence; The GenBank number of landing: NC_012920.1) or the SEQ ID NO:7 in the sequence table design, the primer design scheme is following:
(1) to mtDNA 1494 site; We design two length identical, 3 ' ends and 1494 site wild-type G and corresponding downstream primer N1 of 1494 site mutation type A and M1; Introduce mispairing at two allele-specific primerses 3 ' end the 4th bit base simultaneously; And 3 ' introduce sulfuration phosphoric acid between first of end and second bit base to modify, to strengthen specificity.The reverse primer N1 of the 1494 site wild-types of designing thus is mtDNA nt1494-nt1516, promptly 5 '-CCT TTG AAG TAT ACT TGA GAA G aG-3 ' (put for sulfuration phosphoric acid modifier bit at a place), wherein 1497 G is replaced into A, and this sequence is set at SEQ IDNO:1; The reverse primer M1 of 1494 site mutation types is mtDNA nt1494-nt1516, promptly 5 '-CCT TTGAAG TAT ACT TGA GAA G aA-3 ' (put for sulfuration phosphoric acid modifier bit at a place), wherein 1497 G is replaced into A, and the G in 1494 sites is replaced into A, and this sequence is set at SEQ ID NO:2.Forward primer C1 is a upper reaches universal primer, with N1 or M1 pairing use, is mtDNA nt1030-nt1052, i.e. GGCTTT AAC ATA TCT GAA CAC A aC (put for sulfuration phosphoric acid modifier bit at a place), this sequence is set at SEQ ID NO:3.
(2) to mtDNA 1555 sites; We design two length identical, 3 ' ends and 1555 site wild-type A and corresponding upstream primer N2 of 1555 site mutation type G and M2; Introduce mispairing at two allele-specific primerses 3 ' end the 4th bit base simultaneously; And 3 ' introduce sulfuration phosphoric acid between first of end and second bit base to modify, to strengthen specificity.The forward primer N2 of the 1555 site wild-types of designing thus is mtDNA nt1533-nt1555, promptly 5 '-CCT ACG CAT TTA TAT AGA GAA G aA-3 ' (put for sulfuration phosphoric acid modifier bit at a place), wherein 1552 G is replaced into A, and this sequence is set at SEQ ID NO:4; The forward primer M2 of 1555 site mutation types is mtDNA nt1533-nt1555, promptly 5 '-CCT ACG CAT TTA TAT AGA GAA G aG-3 ' (put for sulfuration phosphoric acid modifier bit at a place), wherein 1552 G is replaced into A, and the A in 1555 sites is replaced into G, and this sequence is set at SEQ ID NO:5.Reverse primer C2 is the downstream universal primer, with N2 or M2 pairing use, is mtDNA nt2214-nt2235, i.e. GGA TTT TTT AGG TAG TGG GTG aT (put for sulfuration phosphoric acid modifier bit at a place), this sequence is set at SEQ ID NO:6.
(3) introducing a size that is produced by C1 and C2 pairing is the constant amplified band of 1206bp, as the molecule internal control index of pcr amplification.
2. the test kit (100 person-portion) that is used for detecting simultaneously matrilinear inheritance drug induced deafness Mitochondrial DNA A1555G and C1494T sudden change comprises following component:
(1) extract the reagent of sample genomic dna: comprise cell pyrolysis liquid 50ml * 2 bottle and solution I 2ml, the staple of cell pyrolysis liquid is the Tris-Cl (pH8.0) of 10mmol/L, the EDTA (pH8.0) of 1mmol/L and the SDS of 0.1% (m/V); The staple of solution I is the Proteinase K of 20mg/ml;
(2) pcr amplification reaction reagent: comprise 2.5mM dNTP mixed solution 800 μ l, 10 * PCR damping fluid 1ml, 25mM MgCl 21ml, 5U/ μ l Taq enzyme 50 μ l, tri-distilled water 1ml * 4 pipes;
(3) primer 2 pipe: concentration is 10 μ M, every pipe 150 μ l; Wherein a pipe is primer C1, N1, N2 and C2 mixed solution, and another pipe is primer C1, M1, M2 and C2 mixed solution, and the primer volume ratio is C1: N1: N2: C2 is 1: 2: 2: 1, and C1: M1: M2: C2 is 1: 2: 2: 1;
(4) carry A1555G sudden change the positive control template, carry the positive control template and the negative control template of C1494T sudden change, the concentration of positive control template and negative control template is 20ng/ μ l, every pipe 300 μ l.The positive control template is the genomic dna that carries A1555G sudden change or C1494T sudden change behind the extraction purifying, and the negative control template is not carry the genomic dna of said mutation.
2. detected object
Select 1 matrilinear inheritance drug induced deafness family (WZD34 family) and 1 matrilinear inheritance drug induced deafness family (WZD102 family) of carrying the C1494T sudden change of carrying the A1555G sudden change.2 family comprehensive conditions are seen table 2, and its pedigree chart is seen Fig. 3.These two familys are matrilinear inheritance drug induced deafness family; All there is the patient to use aminoglycoside antibiotics in each family; Characteristics are that all fell ill early, deaf degree is heavy by aminoglycoside antibiotics if use for maternal member; Then the normal or deaf morbidity of hearing was late if do not use aminoglycoside antibiotics, and degree is light.These two family total numbers of persons are 50 people, and wherein deafness patient has 15 people.In the WZD34 family, it is 2 people that deafness patient receives the inspection number, and it is 1 people that the normal person of hearing receives the inspection number; In the WZD102 family, it is 2 people that deafness patient receives the inspection number, and it is 1 people (referring to table 2) that the normal person of hearing receives the inspection number.
3. the extraction of genomic dna
Obtain these 6 person under inspections' blood filter paper (bleeds) respectively, the blood filter paper is cut into the about 1cm of size with clean scissors 2A scrap of paper put into 1.5ml EP pipe (Eppendorf pipe), add 900 μ l erythrocyte splitting damping fluid (20mmol/L Tris-HCl, pH 7.6) room temperatures and leave standstill 10min, abundant splitting erythrocyte, the centrifugal 1min of 12000rpm collects white corpuscle and precipitates; , the sedimentary 1.5mlEP pipe of white corpuscle adds the cell pyrolysis liquid of 600 μ l and the solution I of 3 μ l, abundant mixing, 55 ℃ of constant temperature digestion cracking 2~3h in being housed; Treat that Digestive system reduces to room temperature, add 200 μ l precooling 5mol/L liquor kalii aceticis, abundant mixing, this moment visible significantly albumen precipitation, 12000rpm-4 ℃ of centrifugal 15min; Get about 700 μ l supernatants and add 600 μ l Virahols in a new 1.5mlEP manages, abundant mixing, behind-20 ℃ of ice bath 30min, the centrifugal 10min of 12000rpm collects the DNA deposition; Add 600 μ l washing with alcohol DNA deposition, the centrifugal 5min of 12000rpm abandons supernatant, treats behind the ethanol volatile dry subsequent use with autoclaving water or TE damping fluid dissolving-20 ℃ of preservations afterwards.
4. multiple allele-specific pcr amplification
6 primer sequences according to above-mentioned design; Obtain 4 pairs of primers through synthetic (entrusting biotech firm); Seized sample genomic dna with said extracted is a template, and the agarose gel electrophoresis that the positive control template that in test kit, provides and negative control template are carried out multiple allele-specific pcr amplification and 2% is identified.Every part of dna sample is that primer C1, N1 and N2, C2 and primer C1, M1 and M2, C2 carry out the MASPCR amplification in two PCR reaction tubess with two pairs of allele-specific primerses respectively; Wherein primer C1, N1, N2 and C2 pairing detect the wild-type site; Primer C1, M1, M2 and C2 pairing detect the mutant site; C1 and C2 can match and produce a constant amplified band, as the molecule internal control index of PCR reaction.
The multiple allele-specific pcr amplification reaction of table 1 system
Figure G2009102232638D00111
Annotate: before the use, all ingredients is diluted to the concentration shown in the table.
The MASPCR loop parameter is 94 ℃ of preparatory sex change 5min, follows 94 ℃ of sex change 30s, 63 ℃ of annealing 30s; 72 ℃ are extended 30s, circulate 8 times, and 1 annealing temperature of every circulation reduces by 1 ℃; 94 ℃ of sex change 30s then, 55 ℃ of annealing 30s, 72 ℃ are extended 30s; After the recirculation 30~35 times, extend 5min again in 72 ℃ at last.PCR product 5~10 μ l electrophoresis in 2% sepharose is observed and the photographic recording result on ultraviolet detector after EB dyeing.
5. experimental result
Can know according to Fig. 4; When the negative control template promptly do not carry plastosome A1555G and C1494T the sudden change genomic dna after two couples of primer C1, N1 and N2, C2 carry out MASPCR; Except producing a constant amplified band of 1206bp, also produce 2 and correspond respectively to the 703bp in 1555 sites, 1494 sites and the normal amplified band of 487bp (referring to Fig. 4 A swimming lane Y7); And after two couples of primer C1, M1 and M2, C2 amplification, only produce the constant amplified band (referring to Fig. 4 B swimming lane Y7) of a 1206bp, prove that this sample does not contain mtDNAA1555G sudden change and C1494T sudden change.
When the genomic dna of the positive control template of carrying plastosome C1494T sudden change after two couples of primer C1, N1 and N2, C2 carry out MASPCR; Except producing a constant amplified band of 1206bp, the normal amplified band (referring to Fig. 4 A swimming lane Y8) of 1 703bp has also appearred; And after two couples of primer C1, M1 and M2, C2 amplification, except producing a constant amplified band of 1206bp, the normal amplified band (referring to Fig. 4 B swimming lane Y8) of 1 487bp has appearred also.
When the genomic dna of the positive control template of carrying plastosome A1555G sudden change after two couples of primer C1, N1 and N2, C2 carry out MASPCR; Except producing a constant amplified band of 1206bp, the normal amplified band (referring to Fig. 4 A swimming lane Y9) of 1 487bp has also appearred; And after two couples of primer C1, M1 and M2, C2 amplification, except producing a constant amplified band of 1206bp, the normal amplified band (referring to Fig. 4 B swimming lane Y9) of 1 703bp has appearred also.
The propositus's of family WZD102 (WZD102-III-1) genomic dna a normal amplified band and the constant amplified band (referring to Fig. 4 A swimming lane Y1) of 1 703bp occurred after two couples of primer C1, N1 and N2, C2 carry out MASPCR; And after two couples of primer C1, M1 and M2, C2 amplification, a sudden change amplified band and the constant amplified band (referring to Fig. 4 B swimming lane Y1) of 1 487bp appearred, proved that this sample carries mtDNA C1494T sudden change.
The propositus of family WZD34 (WZD34-III-2) genomic dna a normal amplified band and the constant amplified band (referring to Fig. 4 A swimming lane Y4) of 1 487bp occurred after two couples of primer C1, N1 and N2, C2 carry out MASPCR; And after two couples of primer C1, M1 and M2, C2 amplification, a sudden change amplified band and the constant amplified band (referring to Fig. 4 B swimming lane Y4) of 1 703bp appearred, proved that this sample carries the mtDNAA1555G sudden change.
In like manner can get, A1555G sudden change and C1494T sudden change (referring to Fig. 4 A swimming lane Y2, Fig. 4 B swimming lane Y2) do not take place in propositus's (WZD102-III-1) father's (WZD102-II-1) mtDNA; Its mother (WZD102-II-2) then carries mtDNA C1494T sudden change (referring to Fig. 4 A swimming lane Y3, Fig. 4 B swimming lane Y3).A1555G sudden change and C1494T sudden change (referring to Fig. 4 A swimming lane Y5, Fig. 4 B swimming lane Y5) do not take place in propositus's (WZD34-III-2) father's (WZD34-II-1) mtDNA; Its mother (WZD34-II-2) then carries mtDNAA1555G sudden change (referring to Fig. 4 A swimming lane Y6, Fig. 4 B swimming lane Y6).
6. certificate authenticity
The individual mtDNA 12S rRNA gene of all examinees all passes through direct sequencing analysis; Sequencing result and multiple allele-specific pcr amplification qualification result match, and the reliability and stability according to test kit of the present invention and method of use detection line mitochondrial DNA A1555G and C1494T sudden change are described.
Table 22 a matrilinear inheritance drug induced deafness family situation and plastosome 1555 sites and 1494 site detected results
Figure G2009102232638D00131
AmAn 1: aminoglycoside antibiotics; MASPCR2: multiple allele-specific pcr amplification.
Embodiment 2
1. identical among the component that comprises of the test kit (100 person-portion) of vitro detection matrilinear inheritance drug induced deafness Mitochondrial DNA A1555G and C1494T sudden change and the embodiment 1.
2. detected object
Select 15 not have the related sporadic deafness patient sample of heredity, obtain the hair of these 15 person under inspections' band hair follicle respectively.
3. detection method
Before extracting the hair follicle cell genomic dna, need carry out corresponding pre-treatment to hair: send out (band hair follicle) 1 time with 70% ethanol scouring of wool, after use the distilled water flushing hair again 2 times; In 1.5ml EP pipe, put into 2~4 hairs respectively, hair follicle places EP pipe bottom, cuts off the part that hair is higher than test tube with clean scissors., the 1.5mlEP pipe of hair (band hair follicle) adds the cell pyrolysis liquid of 600 μ l and the solution I of 3 μ l in being housed, abundant mixing, 55 ℃ of constant temperature digestion cracking 2~3h; Treat that Digestive system reduces to room temperature, add 200 μ l precooling 5mol/L liquor kalii aceticis, abundant mixing, this moment visible significantly albumen precipitation, 12000rpm-4 ℃ of centrifugal 15min; Get about 700 μ l supernatants and add 600 μ l Virahols in a new 1.5mlEP manages, abundant mixing, behind-20 ℃ of ice bath 30min, the centrifugal 10min of 12000rpm collects the DNA deposition; Add 600 μ l washing with alcohol DNA deposition, the centrifugal 5min of 12000rpm abandons supernatant, treats behind the ethanol volatile dry subsequent use with autoclaving water or TE damping fluid dissolving-20 ℃ of preservations afterwards.
The DNA of said extracted that gets about 50ng is as the template of pcr amplification; And the positive control template that in test kit, provides and negative control template are carried out multiple allele-specific pcr amplification; Every part of dna sample is managed primers in two PCR reaction tubess with two respectively; One pipe detects the wild-type site for the mixed solution of primer C1, N1, N2 and C2, and another pipe detects the mutant site for primer C1, M1, M2 and C2 mixed solution.PCR reaction system and loop parameter are seen embodiment 1.PCR product 5~10 μ l electrophoresis in 2% sepharose is observed and the photographic recording result on ultraviolet detector after EB dyeing.
4. interpretation of result and checking
Behind multiple allele-specific pcr amplification, we detect 1 A1555G sudden change positive individuals in 15 deafness patients, do not detect C1494T sudden change positive individuals.Further the pcr amplification product with these samples carries out sequencing analysis, and sequencing result and multiple allele-specific pcr amplification result match, and the reliability and stability of using the inventive method detection line mitochondrial DNA A1555G and C1494T sudden change are described.
Multiple allele-specific round pcr and the enzyme that existing patent relates to are cut authentication method (PCR-RFLP technology), fluorescent quantitative PCR technique and biochip technology and are compared and have following advantage (seeing table 3).
Table 3 this patent and the contrast of other related patent U.S. Patent No. technical indicators
Figure G2009102232638D00151
The above embodiment is the preferred embodiment that proves absolutely that the present invention lifts, and protection scope of the present invention is not limited thereto.Being equal to that the technician in present technique field is done on basis of the present invention substitutes or conversion, all within protection scope of the present invention.
Sequence table
SEQUENCE?LISTING
< 110>Wenzhou Medical College
< 120>be used for test kit and the method for use thereof that while detection line mitochondrial DNA A1555G and C1494T suddenly change
<160>7
<170>PatentIn?version?3.5
<210>1
<211>23
<212>DNA
< 213>artificial sequence
<220>
<221>mutation
<222>(20)..(20)
<220>
<221>modified-base
<222>(23)..(23)
<223>3-terminal?phosphorothioate-modified?nucleotide
<400>1
cctttgaagt?atacttgaga?agg 23
<210>2
<211>23
<212>DNA
< 213>artificial sequence
<220>
<221>mutation
<222>(20)..(20)
<220>
<221>modified-base
<222>(23)..(23)
<223>3-terminal?phosphorothioate-modified?nucleotide
<220>
<221>mutation
<222>(23)..(23)
<400>2
cctttgaagt?atacttgaga?aga 23
<210>3
<211>23
<212>DNA
< 213>artificial sequence
<220>
<221>modified-base
<222>(23)..(23)
<223>3-terminal?phosphorothioate-modified?nucleotide
<400>3
ggctttaaca?tatctgaaca?cac 23
<210>4
<211>23
<212>DNA
< 213>artificial sequence
<220>
<221>mutation
<222>(20)..(20)
<220>
<221>modified-base
<222>(23)..(23)
<223>3-terminal?phosphorothioate-modified?nucleotide
<400>4
cctacgcatt?tatatagaga?aga 23
<210>5
<211>23
<212>DNA
< 213>artificial sequence
<220>
<221>mutation
<222>(20)..(20)
<220>
<221>modified_base
<222>(23)..(23)
<223>3-terminal?phosphorothioate-modified?nucleotide
<220>
<221>mutation
<222>(23)..(23)
<400>5
cctacgcatt?tatatagaga?agg 23
<210>6
<211>22
<212>DNA
< 213>artificial sequence
<220>
<221>modified_base
<222>(22)..(22)
<223>3-terminal?phosphorothioate-modified?nucleotide
<400>6
ggatttttta?ggtagtgggt?gt 22
<210>7
<211>16569
<212>DNA
<213>Homo?sapiens
<220>
<221>misc_feature
<222>(3107)..(3107)
<223>n?is?a,c,g,or?t
<400>7
gatcacaggt?ctatcaccct?attaaccact?cacgggagct?ctccatgcat?ttggtatttt 60
cgtctggggg?gtatgcacgc?gatagcattg?cgagacgctg?gagccggagc?accctatgtc 120
gcagtatctg?tctttgattc?ctgcctcatc?ctattattta?tcgcacctac?gttcaatatt 180
acaggcgaac?atacttacta?aagtgtgtta?attaattaat?gcttgtagga?cataataata 240
acaattgaat?gtctgcacag?ccactttcca?cacagacatc?ataacaaaaa?atttccacca 300
aaccccccct?cccccgcttc?tggccacagc?acttaaacac?atctctgcca?aaccccaaaa 360
acaaagaacc?ctaacaccag?cctaaccaga?tttcaaattt?tatcttttgg?cggtatgcac 420
ttttaacagt?caccccccaa?ctaacacatt?attttcccct?cccactccca?tactactaat 480
ctcatcaata?caacccccgc?ccatcctacc?cagcacacac?acaccgctgc?taaccccata 540
ccccgaacca?accaaacccc?aaagacaccc?cccacagttt?atgtagctta?cctcctcaaa 600
gcaatacact?gaaaatgttt?agacgggctc?acatcacccc?ataaacaaat?aggtttggtc 660
ctagcctttc?tattagctct?tagtaagatt?acacatgcaa?gcatccccgt?tccagtgagt 720
tcaccctcta?aatcaccacg?atcaaaagga?acaagcatca?agcacgcagc?aatgcagctc 780
aaaacgctta?gcctagccac?acccccacgg?gaaacagcag?tgattaacct?ttagcaataa 840
acgaaagttt?aactaagcta?tactaacccc?agggttggtc?aatttcgtgc?cagccaccgc 900
ggtcacacga?ttaacccaag?tcaatagaag?ccggcgtaaa?gagtgtttta?gatcaccccc 960
tccccaataa?agctaaaact?cacctgagtt?gtaaaaaact?ccagttgaca?caaaatagac 1020
tacgaaagtg?gctttaacat?atctgaacac?acaatagcta?agacccaaac?tgggattaga 1080
taccccacta?tgcttagccc?taaacctcaa?cagttaaatc?aacaaaactg?ctcgccagaa 1140
cactacgagc?cacagcttaa?aactcaaagg?acctggcggt?gcttcatatc?cctctagagg 1200
agcctgttct?gtaatcgata?aaccccgatc?aacctcacca?cctcttgctc?agcctatata 1260
ccgccatctt?cagcaaaccc?tgatgaaggc?tacaaagtaa?gcgcaagtac?ccacgtaaag 1320
acgttaggtc?aaggtgtagc?ccatgaggtg?gcaagaaatg?ggctacattt?tctaccccag 1380
aaaactacga?tagcccttat?gaaacttaag?ggtcgaaggt?ggatttagca?gtaaactaag 1440
agtagagtgc?ttagttgaac?agggccctga?agcgcgtaca?caccgcccgt?caccctcctc 1500
aagtatactt?caaaggacat?ttaactaaaa?cccctacgca?tttatataga?ggagacaagt 1560
cgtaacatgg?taagtgtact?ggaaagtgca?cttggacgaa?ccagagtgta?gcttaacaca 1620
aagcacccaa?cttacactta?ggagatttca?acttaacttg?accgctctga?gctaaaccta 1680
gccccaaacc?cactccacct?tactaccaga?caaccttagc?caaaccattt?acccaaataa 1740
agtataggcg?atagaaattg?aaacctggcg?caatagatat?agtaccgcaa?gggaaagatg 1800
aaaaattata?accaagcata?atatagcaag?gactaacccc?tataccttct?gcataatgaa 1860
ttaactagaa?ataactttgc?aaggagagcc?aaagctaaga?cccccgaaac?cagacgagct 1920
acctaagaac?agctaaaaga?gcacacccgt?ctatgtagca?aaatagtggg?aagatttata 1980
ggtagaggcg?acaaacctac?cgagcctggt?gatagctggt?tgtccaagat?agaatcttag 2040
ttcaacttta?aatttgccca?cagaaccctc?taaatcccct?tgtaaattta?actgttagtc 2100
caaagaggaa?cagctctttg?gacactagga?aaaaaccttg?tagagagagt?aaaaaattta 2160
acacccatag?taggcctaaa?agcagccacc?aattaagaaa?gcgttcaagc?tcaacaccca 2220
ctacctaaaa?aatcccaaac?atataactga?actcctcaca?cccaattgga?ccaatctatc 2280
accctataga?agaactaatg?ttagtataag?taacatgaaa?acattctcct?ccgcataagc 2340
ctgcgtcaga?ttaaaacact?gaactgacaa?ttaacagccc?aatatctaca?atcaaccaac 2400
aagtcattat?taccctcact?gtcaacccaa?cacaggcatg?ctcataagga?aaggttaaaa 2460
aaagtaaaag?gaactcggca?aatcttaccc?cgcctgttta?ccaaaaacat?cacctctagc 2520
atcaccagta?ttagaggcac?cgcctgccca?gtgacacatg?tttaacggcc?gcggtaccct 2580
aaccgtgcaa?aggtagcata?atcacttgtt?ccttaaatag?ggacctgtat?gaatggctcc 2640
acgagggttc?agctgtctct?tacttttaac?cagtgaaatt?gacctgcccg?tgaagaggcg 2700
ggcataacac?agcaagacga?gaagacccta?tggagcttta?atttattaat?gcaaacagta 2760
cctaacaaac?ccacaggtcc?taaactacca?aacctgcatt?aaaaatttcg?gttggggcga 2820
cctcggagca?gaacccaacc?tccgagcagt?acatgctaag?acttcaccag?tcaaagcgaa 2880
ctactatact?caattgatcc?aataacttga?ccaacggaac?aagttaccct?agggataaca 2940
gcgcaatcct?attctagagt?ccatatcaac?aatagggttt?acgacctcga?tgttggatca 3000
ggacatcccg?atggtgcagc?cgctattaaa?ggttcgtttg?ttcaacgatt?aaagtcctac 3060
gtgatctgag?ttcagaccgg?agtaatccag?gtcggtttct?atctacnttc?aaattcctcc 3120
ctgtacgaaa?ggacaagaga?aataaggcct?acttcacaaa?gcgccttccc?ccgtaaatga 3180
tatcatctca?acttagtatt?atacccacac?ccacccaaga?acagggtttg?ttaagatggc 3240
agagcccggt?aatcgcataa?aacttaaaac?tttacagtca?gaggttcaat?tcctcttctt 3300
aacaacatac?ccatggccaa?cctcctactc?ctcattgtac?ccattctaat?cgcaatggca 3360
ttcctaatgc?ttaccgaacg?aaaaattcta?ggctatatac?aactacgcaa?aggccccaac 3420
gttgtaggcc?cctacgggct?actacaaccc?ttcgctgacg?ccataaaact?cttcaccaaa 3480
gagcccctaa?aacccgccac?atctaccatc?accctctaca?tcaccgcccc?gaccttagct 3540
ctcaccatcg?ctcttctact?atgaaccccc?ctccccatac?ccaaccccct?ggtcaacctc 3600
aacctaggcc?tcctatttat?tctagccacc?tctagcctag?ccgtttactc?aatcctctga 3660
tcagggtgag?catcaaactc?aaactacgcc?ctgatcggcg?cactgcgagc?agtagcccaa 3720
acaatctcat?atgaagtcac?cctagccatc?attctactat?caacattact?aataagtggc 3780
tcctttaacc?tctccaccct?tatcacaaca?caagaacacc?tctgattact?cctgccatca 3840
tgacccttgg?ccataatatg?atttatctcc?acactagcag?agaccaaccg?aacccccttc 3900
gaccttgccg?aaggggagtc?cgaactagtc?tcaggcttca?acatcgaata?cgccgcaggc 3960
cccttcgccc?tattcttcat?agccgaatac?acaaacatta?ttataataaa?caccctcacc 4020
actacaatct?tcctaggaac?aacatatgac?gcactctccc?ctgaactcta?cacaacatat 4080
tttgtcacca?agaccctact?tctaacctcc?ctgttcttat?gaattcgaac?agcatacccc 4140
cgattccgct?acgaccaact?catacacctc?ctatgaaaaa?acttcctacc?actcacccta 4200
gcattactta?tatgatatgt?ctccataccc?attacaatct?ccagcattcc?ccctcaaacc 4260
taagaaatat?gtctgataaa?agagttactt?tgatagagta?aataatagga?gcttaaaccc 4320
ccttatttct?aggactatga?gaatcgaacc?catccctgag?aatccaaaat?tctccgtgcc 4380
acctatcaca?ccccatccta?aagtaaggtc?agctaaataa?gctatcgggc?ccataccccg 4440
aaaatgttgg?ttataccctt?cccgtactaa?ttaatcccct?ggcccaaccc?gtcatctact 4500
ctaccatctt?tgcaggcaca?ctcatcacag?cgctaagctc?gcactgattt?tttacctgag 4560
taggcctaga?aataaacatg?ctagctttta?ttccagttct?aaccaaaaaa?ataaaccctc 4620
gttccacaga?agctgccatc?aagtatttcc?tcacgcaagc?aaccgcatcc?ataatccttc 4680
taatagctat?cctcttcaac?aatatactct?ccggacaatg?aaccataacc?aatactacca 4740
atcaatactc?atcattaata?atcataatag?ctatagcaat?aaaactagga?atagccccct 4800
ttcacttctg?agtcccagag?gttacccaag?gcacccctct?gacatccggc?ctgcttcttc 4860
tcacatgaca?aaaactagcc?cccatctcaa?tcatatacca?aatctctccc?tcactaaacg 4920
taagccttct?cctcactctc?tcaatcttat?ccatcatagc?aggcagttga?ggtggattaa 4980
accaaaccca?gctacgcaaa?atcttagcat?actcctcaat?tacccacata?ggatgaataa 5040
tagcagttct?accgtacaac?cctaacataa?ccattcttaa?tttaactatt?tatattatcc 5100
taactactac?cgcattccta?ctactcaact?taaactccag?caccacgacc?ctactactat 5160
ctcgcacctg?aaacaagcta?acatgactaa?cacccttaat?tccatccacc?ctcctctccc 5220
taggaggcct?gcccccgcta?accggctttt?tgcccaaatg?ggccattatc?gaagaattca 5280
caaaaaacaa?tagcctcatc?atccccacca?tcatagccac?catcaccctc?cttaacctct 5340
acttctacct?acgcctaatc?tactccacct?caatcacact?actccccata?tctaacaacg 5400
taaaaataaa?atgacagttt?gaacatacaa?aacccacccc?attcctcccc?acactcatcg 5460
cccttaccac?gctactccta?cctatctccc?cttttatact?aataatctta?tagaaattta 5520
ggttaaatac?agaccaagag?ccttcaaagc?cctcagtaag?ttgcaatact?taatttctgt 5580
aacagctaag?gactgcaaaa?ccccactctg?catcaactga?acgcaaatca?gccactttaa 5640
ttaagctaag?cccttactag?accaatggga?cttaaaccca?caaacactta?gttaacagct 5700
aagcacccta?atcaactggc?ttcaatctac?ttctcccgcc?gccgggaaaa?aaggcgggag 5760
aagccccggc?aggtttgaag?ctgcttcttc?gaatttgcaa?ttcaatatga?aaatcacctc 5820
ggagctggta?aaaagaggcc?taacccctgt?ctttagattt?acagtccaat?gcttcactca 5880
gccattttac?ctcaccccca?ctgatgttcg?ccgaccgttg?actattctct?acaaaccaca 5940
aagacattgg?aacactatac?ctattattcg?gcgcatgagc?tggagtccta?ggcacagctc 6000
taagcctcct?tattcgagcc?gagctgggcc?agccaggcaa?ccttctaggt?aacgaccaca 6060
tctacaacgt?tatcgtcaca?gcccatgcat?ttgtaataat?cttcttcata?gtaataccca 6120
tcataatcgg?aggctttggc?aactgactag?ttcccctaat?aatcggtgcc?cccgatatgg 6180
cgtttccccg?cataaacaac?ataagcttct?gactcttacc?tccctctctc?ctactcctgc 6240
tcgcatctgc?tatagtggag?gccggagcag?gaacaggttg?aacagtctac?cctcccttag 6300
cagggaacta?ctcccaccct?ggagcctccg?tagacctaac?catcttctcc?ttacacctag 6360
caggtgtctc?ctctatctta?ggggccatca?atttcatcac?aacaattatc?aatataaaac 6420
cccctgccat?aacccaatac?caaacgcccc?tcttcgtctg?atccgtccta?atcacagcag 6480
tcctacttct?cctatctctc?ccagtcctag?ctgctggcat?cactatacta?ctaacagacc 6540
gcaacctcaa?caccaccttc?ttcgaccccg?ccggaggagg?agaccccatt?ctataccaac 6600
acctattctg?atttttcggt?caccctgaag?tttatattct?tatcctacca?ggcttcggaa 6660
taatctccca?tattgtaact?tactactccg?gaaaaaaaga?accatttgga?tacataggta 6720
tggtctgagc?tatgatatca?attggcttcc?tagggtttat?cgtgtgagca?caccatatat 6780
ttacagtagg?aatagacgta?gacacacgag?catatttcac?ctccgctacc?ataatcatcg 6840
ctatccccac?cggcgtcaaa?gtatttagct?gactcgccac?actccacgga?agcaatatga 6900
aatgatctgc?tgcagtgctc?tgagccctag?gattcatctt?tcttttcacc?gtaggtggcc 6960
tgactggcat?gtattagca aactcatcac?tagacatcgt?actacacgac?acgtactacg 7020
ttgtagccca?cttccactat?gtcctatcaa?taggagctgt?atttgccatc?ataggaggct 7080
tcattcactg?atttccccta?ttctcaggct?acaccctaga?ccaaacctac?gccaaaatcc 7140
atttcactat?catattcatc?ggcgtaaatc?taactttctt?cccacaacac?tttctcggcc 7200
tatccggaat?gccccgacgt?tactcggact?accccgatgc?atacaccaca?tgaaacatcc 7260
tatcatctgt?aggctcattc?atttctctaa?cagcagtaat?attaataatt?ttcatgattt 7320
gagaagcctt?cgcttcgaag?cgaaaagtcc?taatagtaga?agaaccctcc?ataaacctgg 7380
agtgactata?tggatgcccc?ccaccctacc?acacattcga?agaacccgta?tacataaaat 7440
ctagacaaaa?aaggaaggaa?tcgaaccccc?caaagctggt?ttcaagccaa?ccccatggcc 7500
tccatgactt?tttcaaaaag?gtattagaaa?aaccatttca?taactttgtc?aaagttaaat 7560
tataggctaa?atcctatata?tcttaatggc?acatgcagcg?caagtaggtc?tacaagacgc 7620
tacttcccct?atcatagaag?agcttatcac?ctttcatgat?cacgccctca?taatcatttt 7680
ccttatctgc?ttcctagtcc?tgtatgccct?tttcctaaca?ctcacaacaa?aactaactaa 7740
tactaacatc?tcagacgctc?aggaaataga?aaccgtctga?actatcctgc?ccgccatcat 7800
cctagtcctc?atcgccctcc?catccctacg?catcctttac?ataacagacg?aggtcaacga 7860
tccctccctt?accatcaaat?caattggcca?ccaatggtac?tgaacctacg?agtacaccga 7920
ctacggcgga?ctaatcttca?actcctacat?acttccccca?ttattcctag?aaccaggcga 7980
cctgcgactc?cttgacgttg?acaatcgagt?agtactcccg?attgaagccc?ccattcgtat 8040
aataattaca?tcacaagacg?tcttgcactc?atgagctgtc?cccacattag?gcttaaaaac 8100
agatgcaatt?cccggacgtc?taaaccaaac?cactttcacc?gctacacgac?cgggggtata 8160
ctacggtcaa?tgctctgaaa?tctgtggagc?aaaccacagt?ttcatgccca?tcgtcctaga 8220
attaattccc?ctaaaaatct?ttgaaatagg?gcccgtattt?accctatagc?accccctcta 8280
ccccctctag?agcccactgt?aaagctaact?tagcattaac?cttttaagtt?aaagattaag 8340
agaaccaaca?cctctttaca?gtgaaatgcc?ccaactaaat?actaccgtat?ggcccaccat 8400
aattaccccc?atactcctta?cactattcct?catcacccaa?ctaaaaatat?taaacacaaa 8460
ctaccaccta?cctccctcac?caaagcccat?aaaaataaaa?aattataaca?aaccctgaga 8520
accaaaatga?acgaaaatct?gttcgcttca?ttcattgccc?ccacaatcct?aggcctaccc 8580
gccgcagtac?tgatcattct?atttccccct?ctattgatcc?ccacctccaa?atatctcatc 8640
aacaaccgac?taatcaccac?ccaacaatga?ctaatcaaac?taacctcaaa?acaaatgata 8700
accatacaca?acactaaagg?acgaacctga?tctcttatac?tagtatcctt?aatcattttt 8760
attgccacaa?ctaacctcct?cggactcctg?cctcactcat?ttacaccaac?cacccaacta 8820
tctataaacc?tagccatggc?catcccctta?tgagcgggca?cagtgattat?aggctttcgc 8880
tctaagatta?aaaatgccct?agcccacttc?ttaccacaag?gcacacctac?accccttatc 8940
cccatactag?ttattatcga?aaccatcagc?ctactcattc?aaccaatagc?cctggccgta 9000
cgcctaaccg?ctaacattac?tgcaggccac?ctactcatgc?acctaattgg?aagcgccacc 9060
ctagcaatat?caaccattaa?ccttccctct?acacttatca?tcttcacaat?tctaattcta 9120
ctgactatcc?tagaaatcgc?tgtcgcctta?atccaagcct?acgttttcac?acttctagta 9180
agcctctacc?tgcacgacaa?cacataatga?cccaccaatc?acatgcctat?catatagtaa 9240
aacccagccc?atgaccccta?acaggggccc?tctcagccct?cctaatgacc?tccggcctag 9300
ccatgtgatt?tcacttccac?tccataacgc?tcctcatact?aggcctacta?accaacacac 9360
taaccatata?ccaatgatgg?cgcgatgtaa?cacgagaaag?cacataccaa?ggccaccaca 9420
caccacctgt?ccaaaaaggc?cttcgatacg?ggataatcct?atttattacc?tcagaagttt 9480
ttttcttcgc?aggatttttc?tgagcctttt?accactccag?cctagcccct?accccccaat 9540
taggagggca?ctggccccca?acaggcatca?ccccgctaaa?tcccctagaa?gtcccactcc 9600
taaacacatc?cgtattactc?gcatcaggag?tatcaatcac?ctgagctcac?catagtctaa 9660
tagaaaacaa?ccgaaaccaa?ataattcaag?cactgcttat?tacaatttta?ctgggtctct 9720
attttaccct?cctacaagcc?tcagagtact?tcgagtctcc?cttcaccatt?tccgacggca 9780
tctacggctc?aacatttttt?gtagccacag?gcttccacgg?acttcacgtc?attattggct 9840
caactttcct?cactatctgc?ttcatccgcc?aactaatatt?tcactttaca?tccaaacatc 9900
actttggctt?cgaagccgcc?gcctgatact?ggcattttgt?agatgtggtt?tgactatttc 9960
tgtatgtctc?catctattga?tgagggtctt?actcttttag?tataaatagt?accgttaact 10020
tccaattaac?tagttttgac?aacattcaaa?aaagagtaat?aaacttcgcc?ttaattttaa 10080
taatcaacac?cctcctagcc?ttactactaa?taattattac?attttgacta?ccacaactca 10140
acggctacat?agaaaaatcc?accccttacg?agtgcggctt?cgaccctata?tcccccgccc 10200
gcgtcccttt?ctccataaaa?ttcttcttag?tagctattac?cttcttatta?tttgatctag 10260
aaattgccct?ccttttaccc?ctaccatgag?ccctacaaac?aactaacctg?ccactaatag 10320
ttatgtcatc?cctcttatta?atcatcatcc?tagccctaag?tctggcctat?gagtgactac 10380
aaaaaggatt?agactgaacc?gaattggtat?atagtttaaa?caaaacgaat?gatttcgact 10440
cattaaatta?tgataatcat?atttaccaaa?tgcccctcat?ttacataaat?attatactag 10500
catttaccat?ctcacttcta?ggaatactag?tatatcgctc?acacctcata?tcctccctac 10560
tatgcctaga?aggaataata?ctatcgctgt?tcattatagc?tactctcata?accctcaaca 10620
cccactccct?cttagccaat?attgtgccta?ttgccatact?agtctttgcc?gcctgcgaag 10680
cagcggtggg?cctagcccta?ctagtctcaa?tctccaacac?atatggccta?gactacgtac 10740
ataacctaaa?cctactccaa?tgctaaaact?aatcgtccca?acaattatat?tactaccact 10800
gacatgactt?tccaaaaaac?acataatttg?aatcaacaca?accacccaca?gcctaattat 10860
tagcatcatc?cctctactat?tttttaacca?aatcaacaac?aacctattta?gctgttcccc 10920
aaccttttcc?tccgaccccc?taacaacccc?cctcctaata?ctaactacct?gactcctacc 10980
cctcacaatc?atggcaagcc?aacgccactt?atccagtgaa?ccactatcac?gaaaaaaact 11040
ctacctctct?atactaatct?ccctacaaat?ctccttaatt?ataacattca?cagccacaga 11100
actaatcata?ttttatatct?tcttcgaaac?cacacttatc?cccaccttgg?ctatcatcac 11160
ccgatgaggc?aaccagccag?aacgcctgaa?cgcaggcaca?tacttcctat?tctacaccct 11220
agtaggctcc?cttcccctac?tcatcgcact?aatttacact?cacaacaccc?taggctcact 11280
aaacattcta?ctactcactc?tcactgccca?agaactatca?aactcctgag?ccaacaactt 11340
aatatgacta?gcttacacaa?tagcttttat?agtaaagata?cctctttacg?gactccactt 11400
atgactccct?aaagcccatg?tcgaagcccc?catcgctggg?tcaatagtac?ttgccgcagt 11460
actcttaaaa?ctaggcggct?atggtataat?acgcctcaca?ctcattctca?accccctgac 11520
aaaacacata?gcctacccct?tccttgtact?atccctatga?ggcataatta?taacaagctc 11580
catctgccta?cgacaaacag?acctaaaatc?gctcattgca?tactcttcaa?tcagccacat 11640
agccctcgta?gtaacagcca?ttctcatcca?aaccccctga?agcttcaccg?gcgcagtcat 11700
tctcataatc?gcccacgggc?ttacatcctc?attactattc?tgcctagcaa?actcaaacta 11760
cgaacgcact?cacagtcgca?tcataatcct?ctctcaagga?cttcaaactc?tactcccact 11820
aatagctttt?tgatgacttc?tagcaagcct?cgctaacctc?gccttacccc?ccactattaa 11880
cctactggga?gaactctctg?tgctagtaac?cacgttctcc?tgatcaaata?tcactctcct 11940
acttacagga?ctcaacatac?tagtcacagc?cctatactcc?ctctacatat?ttaccacaac 12000
acaatggggc?tcactcaccc?accacattaa?caacataaaa?ccctcattca?cacgagaaaa 12060
caccctcatg?ttcatacacc?tatcccccat?tctcctccta?tccctcaacc?ccgacatcat 12120
taccgggttt?tcctcttgta?aatatagttt?aaccaaaaca?tcagattgtg?aatctgacaa 12180
cagaggctta?cgacccctta?tttaccgaga?aagctcacaa?gaactgctaa?ctcatgcccc 12240
catgtctaac?aacatggctt?tctcaacttt?taaaggataa?cagctatcca?ttggtcttag 12300
gccccaaaaa?ttttggtgca?actccaaata?aaagtaataa?ccatgcacac?tactataacc 12360
accctaaccc?tgacttccct?aattcccccc?atccttacca?ccctcgttaa?ccctaacaaa 12420
aaaaactcat?acccccatta?tgtaaaatcc?attgtcgcat?ccacctttat?tatcagtctc 12480
ttccccacaa?caatattcat?gtgcctagac?caagaagtta?ttatctcgaa?ctgacactga 12540
gccacaaccc?aaacaaccca?gctctcccta?agcttcaaac?tagactactt?ctccataata 12600
ttcatccctg?tagcattgtt?cgttacatgg?tccatcatag?aattctcact?gtgatatata 12660
aactcagacc?caaacattaa?tcagttcttc?aaatatctac?tcatcttcct?aattaccata 12720
ctaatcttag?ttaccgctaa?caacctattc?caactgttca?tcggctgaga?gggcgtagga 12780
attatatcct?tcttgctcat?cagttgatga?tacgcccgag?cagatgccaa?cacagcagcc 12840
attcaagcaa?tcctatacaa?ccgtatcggc?gatatcggtt?tcatcctcgc?cttagcatga 12900
tttatcctac?actccaactc?atgagaccca?caacaaatag?cccttctaaa?cgctaatcca 12960
agcctcaccc?cactactagg?cctcctccta?gcagcagcag?gcaaatcagc?ccaattaggt 13020
ctccacccct?gactcccctc?agccatagaa?ggccccaccc?cagtctcagc?cctactccac 13080
tcaagcacta?tagttgtagc?aggaatcttc?ttactcatcc?gcttccaccc?cctagcagaa 13140
aatagcccac?taatccaaac?tctaacacta?tgcttaggcg?ctatcaccac?tctgttcgca 13200
gcagtctgcg?cccttacaca?aaatgacatc?aaaaaaatcg?tagccttctc?cacttcaagt 13260
caactaggac?tcataatagt?tacaatcggc?atcaaccaac?cacacctagc?attcctgcac 13320
atctgtaccc?acgccttctt?caaagccata?ctatttatgt?gctccgggtc?catcatccac 13380
aaccttaaca?atgaacaaga?tattcgaaaa?ataggaggac?tactcaaaac?catacctctc 13440
acttcaacct?ccctcaccat?tggcagccta?gcattagcag?gaataccttt?cctcacaggt 13500
ttctactcca?aagaccacat?catcgaaacc?gcaaacatat?catacacaaa?cgcctgagcc 13560
ctatctatta?ctctcatcgc?tacctccctg?acaagcgcct?atagcactcg?aataattctt 13620
ctcaccctaa?caggtcaacc?tcgcttcccc?acccttacta?acattaacga?aaataacccc 13680
accctactaa?accccattaa?acgcctggca?gccggaagcc?tattcgcagg?atttctcatt 13740
actaacaaca?tttcccccgc?atcccccttc?caaacaacaa?tccccctcta?cctaaaactc 13800
acagccctcg?ctgtcacttt?cctaggactt?ctaacagccc?tagacctcaa?ctacctaacc 13860
aacaaactta?aaataaaatc?cccactatgc?acattttatt?tctccaacat?actcggattc 13920
taccctagca?tcacacaccg?cacaatcccc?tatctaggcc?ttcttacgag?ccaaaacctg 13980
cccctactcc?tcctagacct?aacctgacta?gaaaagctat?tacctaaaac?aatttcacag 14040
caccaaatct?ccacctccat?catcacctca?acccaaaaag?gcataattaa?actttacttc 14100
ctctctttct?tcttcccact?catcctaacc?ctactcctaa?tcacataacc?tattcccccg 14160
agcaatctca?attacaatat?atacaccaac?aaacaatgtt?caaccagtaa?ctactactaa 14220
tcaacgccca?taatcataca?aagcccccgc?accaatagga?tcctcccgaa?tcaaccctga 14280
cccctctcct?tcataaatta?ttcagcttcc?tacactatta?aagtttacca?caaccaccac 14340
cccatcatac?tctttcaccc?acagcaccaa?tcctacctcc?atcgctaacc?ccactaaaac 14400
actcaccaag?acctcaaccc?ctgaccccca?tgcctcagga?tactcctcaa?tagccatcgc 14460
tgtagtatat?ccaaagacaa?ccatcattcc?ccctaaataa?attaaaaaaa?ctattaaacc 14520
catataacct?cccccaaaat?tcagaataat?aacacacccg?accacaccgc?taacaatcaa 14580
tactaaaccc?ccataaatag?gagaaggctt?agaagaaaac?cccacaaacc?ccattactaa 14640
acccacactc?aacagaaaca?aagcatacat?cattattctc?gcacggacta?caaccacgac 14700
caatgatatg?aaaaaccatc?gttgtatttc?aactacaaga?acaccaatga?ccccaatacg 14760
caaaactaac?cccctaataa?aattaattaa?ccactcattc?atcgacctcc?ccaccccatc 14820
caacatctcc?gcatgatgaa?acttcggctc?actccttggc?gcctgcctga?tcctccaaat 14880
caccacagga?ctattcctag?ccatgcacta?ctcaccagac?gcctcaaccg?ccttttcatc 14940
aatcgcccac?atcactcgag?acgtaaatta?tggctgaatc?atccgctacc?ttcacgccaa 15000
tggcgcctca?atattcttta?tctgcctctt?cctacacatc?gggcgaggcc?tatattacgg 15060
atcatttctc?tactcagaaa?cctgaaacat?cggcattatc?ctcctgcttg?caactatagc 15120
aacagccttc?ataggctatg?tcctcccgtg?aggccaaata?tcattctgag?gggccacagt 15180
aattacaaac?ttactatccg?ccatcccata?cattgggaca?gacctagttc?aatgaatctg 15240
aggaggctac?tcagtagaca?gtcccaccct?cacacgattc?tttacctttc?acttcatctt 15300
gcccttcatt?attgcagccc?tagcaacact?ccacctccta?ttcttgcacg?aaacgggatc 15360
aaacaacccc?ctaggaatca?cctcccattc?cgataaaatc?accttccacc?cttactacac 15420
aatcaaagac?gccctcggct?tacttctctt?ccttctctcc?ttaatgacat?taacactatt 15480
ctcaccagac?ctcctaggcg?acccagacaa?ttatacccta?gccaacccct?taaacacccc 15540
tccccacatc?aagcccgaat?gatatttcct?attcgcctac?acaattctcc?gatccgtccc 15600
taacaaacta?ggaggcgtcc?ttgccctatt?actatccatc?ctcatcctag?caataatccc 15660
catcctccat?atatccaaac?aacaaagcat?aatatttcgc?ccactaagcc?aatcacttta 15720
ttgactccta?gccgcagacc?tcctcattct?aacctgaatc?ggaggacaac?cagtaagcta 15780
cccttttacc?atcattggac?aagtagcatc?cgtactatac?ttcacaacaa?tcctaatcct 15840
aataccaact?atctccctaa?ttgaaaacaa?aatactcaaa?tgggcctgtc?cttgtagtat 15900
aaactaatac?accagtcttg?taaaccggag?atgaaaacct?ttttccaagg?acaaatcaga 15960
gaaaaagtct?ttaactccac?cattagcacc?caaagctaag?attctaattt?aaactattct 16020
ctgttctttc?atggggaagc?agatttgggt?accacccaag?tattgactca?cccatcaaca 16080
accgctatgt?atttcgtaca?ttactgccag?ccaccatgaa?tattgtacgg?taccataaat 16140
acttgaccac?ctgtagtaca?taaaaaccca?atccacatca?aaaccccctc?cccatgctta 16200
caagcaagta?cagcaatcaa?ccctcaacta?tcacacatca?actgcaactc?caaagccacc 16260
cctcacccac?taggatacca?acaaacctac?ccacccttaa?cagtacatag?tacataaagc 16320
catttaccgt?acatagcaca?ttacagtcaa?atcccttctc?gtccccatgg?atgacccccc 16380
tcagataggg?gtcccttgac?caccatcctc?cgtgaaatca?atatcccgca?caagagtgct 16440
actctcctcg?ctccgggccc?ataacacttg?ggggtagcta?aagtgaactg?tatccgacat 16500
ctggttccta?cttcagggtc?ataaagccta?aatagcccac?acgttcccct?taaataagac 16560
atcacgatg 16569

Claims (6)

1. be used for detecting simultaneously the test kit of Mitochondrial DNA A1555G relevant and C1494T sudden change, it is characterized in that, comprising with the matrilinear inheritance drug induced deafness:
(1) reagent of extraction sample genomic dna;
(2) pcr amplification reaction reagent comprises dNTP, 10 * PCR damping fluid, MgCl 2, Taq enzyme and tri-distilled water;
(3) two pipe primers, wherein a pipe is the mixed solution of primer C1, N1, N2 and C2, another pipe is the mixed solution of primer C1, M1, M2 and C2;
Said two pipe primers are according to the human mtdna sequences Design shown in the SEQ ID NO:7; Article one, primer sequence N1 is an antisense strand; Being the downstream universal primer, is the Nucleotide 1494-1516 of Mitochondrial DNA, and its sequence is the SEQ ID NO:1 in the sequence table; Second primer sequence M1 is an antisense strand, is the downstream universal primer, is the Nucleotide 1494-1516 of Mitochondrial DNA, and wherein the G in 1494 sites is replaced into A, and its sequence is the SEQ ID NO:2 in the sequence table; Article three, primer sequence C1 is a sense strand, is upper reaches universal primer, is the Nucleotide 1030-1052 of Mitochondrial DNA, and its sequence is the SEQ ID NO:3 in the sequence table; Article four, primer sequence N2 is a sense strand, is upper reaches universal primer, is the Nucleotide 1533-1555 of Mitochondrial DNA, and its sequence is the SEQ ID NO:4 in the sequence table; Article five, primer sequence M2 is a sense strand, is upper reaches universal primer, is the Nucleotide 1533-1555 of Mitochondrial DNA, and wherein the A in 1555 sites is replaced into G, and its sequence is the SEQ ID NO:5 in the sequence table; Article six, primer sequence C2 is an antisense strand, is the downstream universal primer, is the Nucleotide 2214-2235 of Mitochondrial DNA, and its sequence is the SEQ ID NO:6 in the sequence table;
(4) carry A1555G sudden change the positive control template, carry the positive control template and the negative control template of C1494T sudden change.
2. the test kit that is used for detecting simultaneously Mitochondrial DNA A1555G relevant and C1494T sudden change according to claim 1 with the matrilinear inheritance drug induced deafness; It is characterized in that; 3 ' end of primer N1 and M1 is positioned at 1494 sites of Mitochondrial DNA, corresponds respectively to 1494 site wild-type G and mutant A; 3 ' end of primer N2 and M2 is positioned at 1555 sites of Mitochondrial DNA, corresponds respectively to 1555 site wild-type A and mutant G.
3. the test kit that is used for detecting simultaneously Mitochondrial DNA A1555G relevant and C1494T sudden change according to claim 1 with the matrilinear inheritance drug induced deafness; It is characterized in that; Introduce sulfuration phosphoric acid between first of every primer 3 ' end and second bit base and modify, and 3 ' end the 4th bit base of primer N1, M1, N2, M2 introduces mispairing, promptly be replaced into A corresponding to mitochondrial 1497 G; 1552 G is replaced into A, to improve the specificity of extension.
4. according to each described test kit that is used for detecting simultaneously Mitochondrial DNA A1555G relevant and C1494T sudden change of claim 1~3 with the matrilinear inheritance drug induced deafness; It is characterized in that; In said primer; N1 and C1 pairing is used to increase and contains the mitochondria DNA fragment in the normal site of C1494C; N2 and C2 pairing is used to increase and contains the mitochondria DNA fragment in the normal site of A1555A, and pairing is used to increase and contains the mitochondria DNA fragment in C1494T mutational site M1 with C1, and M2 and C2 match to be used to increase and contain the mitochondria DNA fragment in A1555G mutational site; Primer C1 and C2 pairing are used to generate a constant amplified band, as the molecule internal control index of PCR reaction.
5. the test kit that is used for detecting simultaneously Mitochondrial DNA A1555G relevant and C1494T sudden change according to claim 1 with the matrilinear inheritance drug induced deafness; It is characterized in that; In the reagent of said extraction sample genomic dna; Comprise cell pyrolysis liquid and solution I, the staple of said solution I is a Proteinase K.
6. the test kit that is used for detecting simultaneously Mitochondrial DNA A1555G relevant and C1494T sudden change according to claim 1 with the matrilinear inheritance drug induced deafness; It is characterized in that interpolation is used to improve the specific DMSO 99.8MIN. of extension in said pcr amplification reaction reagent.
CN2009102232638A 2009-11-20 2009-11-20 Kit for simultaneously detecting mutations in mitochondria DNA A1555G and C1494T and using method thereof Expired - Fee Related CN101768637B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102232638A CN101768637B (en) 2009-11-20 2009-11-20 Kit for simultaneously detecting mutations in mitochondria DNA A1555G and C1494T and using method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102232638A CN101768637B (en) 2009-11-20 2009-11-20 Kit for simultaneously detecting mutations in mitochondria DNA A1555G and C1494T and using method thereof

Publications (2)

Publication Number Publication Date
CN101768637A CN101768637A (en) 2010-07-07
CN101768637B true CN101768637B (en) 2012-01-04

Family

ID=42501737

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102232638A Expired - Fee Related CN101768637B (en) 2009-11-20 2009-11-20 Kit for simultaneously detecting mutations in mitochondria DNA A1555G and C1494T and using method thereof

Country Status (1)

Country Link
CN (1) CN101768637B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101988123A (en) * 2010-08-24 2011-03-23 中国医学科学院医学实验动物研究所 Human mitochondria DNA specific fragment amplification detection method for human cells
CN102146443B (en) * 2011-01-06 2013-01-16 中国科学院昆明动物研究所 Specific primer for detecting Leber hereditary optic neuropathy mitochondrial DNA mutation G10680A
CN102220434B (en) * 2011-05-27 2013-06-12 危梅娟 Hybrid membrane strip, PCR primer and kit for diagnosis of NSHI
CN103276082A (en) * 2013-05-30 2013-09-04 博奥生物有限公司 Kit for detecting mutation sites of drug-induced deafness susceptible gene
CN103451302A (en) * 2013-09-11 2013-12-18 步迅 Deafness susceptible gene mitochondrion 12SrDNA 1555A>G and 1494C>T mutant ratio detection kit
CN105586402A (en) * 2015-12-16 2016-05-18 北京晋祺生物科技有限公司 Detection primer set for drug-induced epicophosis, reaction system constituted by detection primer set and application of detection primer set
CN108588213A (en) * 2018-05-02 2018-09-28 宁波美丽人生医药生物科技发展有限公司 Aminoglycoside medicaments correlation 12s rRNA gene mutation site detection kits
CN111996279A (en) * 2020-08-31 2020-11-27 中国农业科学院蔬菜花卉研究所 Method for detecting succinate dehydrogenase D subunit point mutation type of corynebacterium polygamum and primer composition used in method
CN112908411B (en) * 2021-01-12 2024-05-14 广州市金域转化医学研究院有限公司 Mitochondrial variation site database and establishment method and application thereof
CN112852948B (en) * 2021-02-08 2023-03-24 广东药科大学 Method and kit for detecting drug-induced deafness related gene locus

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1490415A (en) * 2003-09-10 2004-04-21 朴 戴 Testing method for matrilinear hereditary deaf mitochondria gene 1555 place A-G catastrophe and reagent boxes
CN101445779A (en) * 2009-01-04 2009-06-03 朱洪 Device for water-surface aquaculture engineering and construction method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1490415A (en) * 2003-09-10 2004-04-21 朴 戴 Testing method for matrilinear hereditary deaf mitochondria gene 1555 place A-G catastrophe and reagent boxes
CN101445779A (en) * 2009-01-04 2009-06-03 朱洪 Device for water-surface aquaculture engineering and construction method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
刘琪,等.核修饰基因和线粒体DNA 突变致耳聋的机制及其功能研究.《听力学及言语疾病杂志》.2009,第17卷(第4期),392-934. *
唐霄雯,等.线粒体tRNAThr G15927A 突变可能影响耳聋相关的12S rRNA A1555G突变的表型表达.《遗传》.2008,第30卷(第10期),1287―1294. *
赵辉,等.药物性聋和非综合征性聋相关的线粒体DNAC1494T 突变对细胞功能的影响.《中华耳科学杂志》.2008,第6卷(第2期),148-156. *

Also Published As

Publication number Publication date
CN101768637A (en) 2010-07-07

Similar Documents

Publication Publication Date Title
CN101768637B (en) Kit for simultaneously detecting mutations in mitochondria DNA A1555G and C1494T and using method thereof
CN102747152A (en) Kit for detecting regulon of Leber disease and use thereof
EP1634966B1 (en) Methods for detection of nucleic acid sequences in urine
US20100285984A1 (en) Assessing t cell repertoires
CN107849607A (en) The single-molecule sequencing of plasma dna
CN102834525B (en) Use the method for PCR and the HLA somatotype of crude blood
CN103266169B (en) Kit for detecting deaf related mitochondrial T7505C mutation, and application thereof
CN106755399B (en) A kind of I type neurofibromatosis pathogenic mutation gene and the Etiologic reagent based on this mutated gene
CN103031379A (en) Kit for detecting mitochondria DNA A4401G related to hypertension and application
CN103290114B (en) Kit for detecting mutation of mitochondria T12201C related with epicophosis and application
CN103173544B (en) Mitochondrial T3866C detection kit of Leber disease, and application thereof
JP2004201679A (en) Primer for detecting fusobacterium nucleatum by pcr process and method for detecting the same
AU2018361590A1 (en) Method for estimating periodontal pocket inflammation area
Fesenko et al. HLA-DQA1, AB0, and AMEL genotyping of biological material with biochips
CN103031380B (en) Kit for detecting mitochondria DNA A4263G related to hypertension and application
US10036071B2 (en) Methods for the detection of sequence amplification in the BRCA1 locus
JP2009005698A (en) Microsatellite sequence for canine genotyping
CN103173545B (en) The plastosome T12338C detection kit of Leber disease and application
CN104774927B (en) Mitochondrion T14502C kit for detecting Leber disease
CN103290110B (en) Kit for detecting mitochondrial T5655C mutation linked to hypertension and application thereof
CN103290109B (en) Kit for detecting mitochondrial T4353C mutation linked to hypertension and application thereof
CN113215241A (en) Detection primer group for risk early warning of cardiovascular and cerebrovascular diseases and application thereof
CN104774926A (en) T3394C kit for detecting Leber disease
JP4347609B2 (en) Bladder cancer test kit
JP2017201894A (en) Diabetes examination method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120104

Termination date: 20181120